Architect Insulin Controls - Vietnam Registration 166301

Access comprehensive regulatory information for Architect Insulin Controls in Vietnam's medical device market through Pure Global AI's free database. is registered under number 166301 and manufactured by Denka Seiken Co., Ltd.. The authorized representative in Vietnam is CENTRAL PHARMACEUTICAL JOINT STOCK COMPANY 2.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.